global-newborn-screening-testing-market-industry
Published

August 2016

Global Newborn Screening Market - Industry Analysis and Market Forecast (2015-2020)

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license

The global newborn screening market is expected to reach USD XX million by 2021, growing at a CAGR of XX%. Newborn screening is performed to screen infants after birth for the detection of any health conditions or diseases that can be fatal but are not detected during birth. The newborn screening tests are basically an evaluation of metabolites and blood samples. These tests vary according to different country jurisdictions. In many areas, newborn screening tests include screening for hearing loss and congenital heart disease. The major diseases screened for are sickle cell disease, cystic fibrosis, newborn hearing loss, congenital hypothyroidism, phenyl ketone urea and congenital heart disease.

Global Newborn Screening Market- Market Dynamics

The report details several driving and restraining factors for the global newborn screening market. Some of them are listed below.

Drivers

  • Presence of federal bodies for organizing awareness programs
  • Increasing awareness in developed countries
  • Technological advancements in healthcare
  • Increasing array of newborn diseases
  • More physicians advising newborn screening tests

Restraints

  • Lack of awareness in developing countries
  • Lack of trained professionals
  • Socio-economic barriers in developing countries

The global newborn screening market has been segmented based on technology, product, test type, and geography. The segmentation based on technology has been subdivided into tandem mass spectrometry, DNA-based assay, enzyme, and immunoassays, electrophoresis, hearing screening technology, and pulse oximetry technology. The segmentation based on product is sub-divided into newborn disorder screening instruments, hearing screening devices and accessories, pulse oximetry, and reagents and assay kits. The segmentation based on test type has been sub-divided into critical congenital heart disease test, hearing screening test, and dry blood spot test.

Amongst technologies being used, tandem mass spectrometry is expected to have the highest growth rate during the forecast period. The dry blood spot test has the largest market share in the segment by test type.

Based on geography, the global newborn screening test market has been segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and South America. The segmentation on North America discusses different market trends, and market size of newborn screening tests in the USA, Canada, and Mexico. The Europe segment has been further subdivided into UK, France, Italy, Germany, Benelux, Scandinavia, Spain and Portugal. The segmentation on Asia-Pacific has been subdivided into China, Japan, India, South Korea, Australia, and New Zealand. The Middle-east & North Africa segment includes GCC, Egypt, and others. The South America region includes Brazil, Argentina, Colombia and others.

Some of the key players in the market are:

  • AB Sciex LLC
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Covidien PLC
  • PerkinElmer Inc.
  • Trivitron Healthcare

 What the Report Offers

  • Market definition for the global newborn screening market along with identification of key drivers and restraints for the market.
  • Market analysis for the newborn screening test market, with region-specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
  • Identification and analysis of the macro and micro factors that affect the newborn screening test market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
RELATED REPORTS
No related reports available.
Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license
Our Clients Include View All

Looking to Customize Report?